TWIST BIOSCIENCE CORP (TWST) Stock Price, Quote, News and Overview
NASDAQ:TWST - Nasdaq - US90184D1000 - Common Stock - Currency: USD
TWST Quote, Performance and Key Statistics
TWIST BIOSCIENCE CORP
NASDAQ:TWST (1/29/2025, 8:00:02 PM)
After market: 49.52 0 (0%)49.52
-2.34 (-4.51%)
The current stock price of TWST is 49.52 USD. In the past month the price increased by 2.81%. In the past year, price increased by 35.34%.
TWST Latest News, Press Releases and Analysis
Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
/PRNewswire/ -- Healthcare is undergoing a transformative shift, with new technologies enabling breakthroughs that were once unimaginable. According to the...
Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
TWST Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.3 | 309.71B | ||
| AMGN | AMGEN INC | 14.66 | 151.41B | ||
| GILD | GILEAD SCIENCES INC | 21.58 | 119.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 865.73 | 113.70B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.52B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.15B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.34B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.20B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.14B | ||
| NTRA | NATERA INC | N/A | 22.21B | ||
| BIIB | BIOGEN INC | 8.84 | 21.04B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.37 | 16.64B |
Related stock screener links
About TWST
Company Profile
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 923 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The firm leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. The company has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. The company offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. The company offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.
Company Info
TWIST BIOSCIENCE CORP
681 Gateway Blvd.
South San Francisco CALIFORNIA 94080 US
CEO: Emily M. Leproust
Employees: 919
Company Website: https://www.twistbioscience.com/
Investor Relations: https://investors.twistbioscience.com/
Phone: 18007190671
TWST FAQ
What is the stock price of TWST?
The current stock price of TWST is 49.52 USD.
What is the symbol for TWIST BIOSCIENCE CORP stock?
The exchange symbol of TWIST BIOSCIENCE CORP is TWST and it is listed on the Nasdaq exchange.
On which exchange is TWST stock listed?
TWST stock is listed on the Nasdaq exchange.
Is TWST a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TWST, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TWST.
Does TWST stock pay dividends?
TWST does not pay a dividend.
When does TWST stock report earnings?
TWST will report earnings on 2025-02-03, before the market open.
What is the Price/Earnings (PE) ratio of TWST?
TWST does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.6).
What is the Short Interest ratio of TWST stock?
The outstanding short interest for TWST is 15.02% of its float.
TWST Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TWST. When comparing the yearly performance of all stocks, TWST is one of the better performing stocks in the market, outperforming 86.09% of all stocks.
TWST Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to TWST. While TWST has a great health rating, there are worries on its profitability.
TWST Financial Highlights
Over the last trailing twelve months TWST reported a non-GAAP Earnings per Share(EPS) of -3.6. The EPS increased by -6.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.98% | ||
| ROE | -44.16% | ||
| Debt/Equity | 0 |
TWST Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to TWST. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 33.28% and a revenue growth 20.11% for TWST